Finding a skilled psoriasis doctor in Mumbai may have a big impact on the health of people looking for professional care.

GLP-1 agonists appeared to have a bigger impact on the physical and mental health of patients with psoriasis compared with other patients, a large retrospective cohort study showed. Reductions in ...

Sept. 19, 2025 -- Psoriasis is more than skin deep -- it’s a chronic inflammatory condition that raises the risk of serious health issues like depression, heart disease, and substance use. An emerging ...

Major advancements in psoriasis treatments in the past two decades have given people living with the autoimmune condition a wide range of options for controlling symptoms. There are more than a dozen ...

"Psoriasis is a systemic inflammatory disease in which lipid dysregulation contributes to cardiovascular disease," explained Dr. Treichel. "Because abnormal lipid deposition in the retina is a ...

PARIS — Clinicians should consider treating their patients with psoriasis with GLP-1 receptor agonists (RAs), when appropriate, as these drugs appear to confer considerable additional benefits beyond ...

Very few studies have examined the relationship between psoriasis and addiction. But the results we do have show a possible link. One survey carried out by researchers in Germany looked at people ...

New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing ...

Significantly higher risk for psoriasis noted, especially among those with high genetic risk. (HealthDay News) — Poor cardiovascular-kidney-metabolic (CKM) health is associated with an increased risk ...

Johnson & Johnson JNJ has submitted a regulatory filing to the European Medicines Agency (EMA) to seek approval for its investigational oral peptide, icotrokinra, to treat moderate-to-severe plaque ...

Sept 17 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb's (BMY.N), opens new ...

FRIDAY, Sept. 19, 2025 (HealthDay News) -- Psoriasis is associated with an increased risk for age-related macular degeneration (AMD), with increased risks seen for exudative and nonexudative AMD, ...